Daily Moisturizing Lotion for Normal To Dry Skin 12 Fl Oz

Ayzeze: This product may cause an allergic reaction. Before use, read the instructions and information on the package. For more information, you can contact the seller or manufacturer directly.

-----

Ayzeze: This device is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare professional before use if in doubt. The seller/distributor is not liable for any damages arising from misuse, unauthorized modification, or use beyond stated indications.

-----

CeraVe® DEVELOPED WITH DERMATOLOGISTS

Daily Moisturizing Lotion For Normal to Dry Skin

Moisturizes & helps restore the protective skin barrier

With 3 essential ceramides & hyaluronic acid

LIGHTWEIGHT ACCEPTED NATIONALECZEMA.ORG • NATIONAL Eczema ASSOCIATION

12 fl oz (355 ml)

CeraVe® Daily Moisturizing Lotion

Developed with dermatologists, its unique formula-with 3 essential ceramides-moisturizes and helps restore the protective skin barrier.

• MVE® Delivery Technology - Controlled release for all day hydration • Lightweight & Oil Free - Non-comedogenic, won't clog pores • Hyaluronic Acid - Helps retain skin's natural moisture • Fragrance Free - To avoid fragrance irritation

Gentle on skin | Allergy tested | Non-comedogenic

Warning:

Avoid direct contact with eyes. If contact occurs rinse thoroughly with water.

Directions:

Apply liberally as often as needed, or as directed by a physician. Avoid direct contact with eyes. If contact occurs rinse thoroughly with water.

20215004V01 - Ingredients:

Aqua / Water / Eau, Glycerin, Caprylic / Capric Triglyceride, Cetearyl Alcohol, Cetyl Alcohol, Potassium Phosphate, Ceramide NP, Ceramide AP, Ceramide EOP, Carbomer, Dimethicone, Ceteareth-20, Behentrimonium Methosulfate, Methylparaben, Sodium Lauroyl Lactylate, Cholesterol, Disodium Edta, Dipotassium Phosphate, Propylparaben, Hydrolyzed Hyaluronic Acid, PHYTOSPHINGOSINE, Xanthan Gum, Polysorbate 20, Polyglyceryl-3, DIISOSTEARATE (Code F.I.L. D215763/2)